Top

Neurocritical Care

Published in:

01-12-2015 | Practical Pearl

Failure of Induced Hypertension for Symptomatic Vasospasm in the Setting of Clozapine Therapy

Authors: Jonathan G. Leung, Sarah Nelson, Sara Hocker

Published in: Neurocritical Care | Issue 3/2015

Abstract

Background

Hemodynamic augmentation is utilized as a treatment in the setting of symptomatic cerebral vasospasm. This approach includes the use of vasopressors to induce hypertension with the aim of improved cerebral blood flow. Agents with potent alpha-1 antagonism properties, including clozapine, can inhibit or blunt the response of several vasopressor agents.

Methods

Case report.

Results

A 54-year-old schizophrenic male with an aneurysmal subarachnoid hemorrhage required hemodynamic augmentation in which several vasopressor trials resulted in no or poor response. The addition of epinephrine resulted in a decrease of mean arterial pressure. Vasopressin initiation demonstrated an immediate vasopressor effect.

Conclusions

Vasopressors are an important treatment modality in symptomatic cerebral vasospasm. This case highlights the potential for clozapine to blunt the effects of vasopressors; or in the case of epinephrine, it causes a reversal effect. Vasopressin may be considered an agent of choice in patients who have recently taken clozapine and require hemodynamic augmentation.

Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–37.CrossRefPubMed

Baldwin ME, Macdonald RL, Huo D, et al. Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke. 2004;35:2506–11.CrossRefPubMed

Macdonald RL, Hunsche E, Schuler R, Wlodarczyk J, Mayer SA. Quality of life and healthcare resource use associated with angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2012;43:1082–8.CrossRefPubMed

Meltzer HY. An overview of the mechanism of action of clozapine. J Clin Psychiatry. 1994;55(Suppl B):47–52.PubMed

Clozapine [package insert]. Mylan Pharmaceuticals Inc., Morgantown, WV; 2014.

Hollenberg SM. Vasoactive drugs in circulatory shock. Am J Respir Crit Care Med. 2011;183:847–55.CrossRefPubMed

John A, Yeh C, Boyd J, Greilich PE. Treatment of refractory hypotension with low-dose vasopressin in a patient receiving clozapine. J Cardiothorac Vasc Anesth. 2010;24:467–8.CrossRefPubMed

Janowsky EC, Risch C, Janowsky DS. Effects of anesthesia on patients taking psychotropic drugs. J Clin Psychopharmacol. 1981;1:14–20.CrossRefPubMed

Rotella JA, Zarei F, Frauman AG, Greene SL. Refractory hypotension treated with vasopressin after intentional clozapine overdose. Eur J Emerg Med. 2014;21:319–20.CrossRefPubMed

10.

Hawkins DJ, Unwin P. Paradoxical and severe hypotension in response to adrenaline infusions in massive quetiapine overdose. Crit Care Resusc. 2008;10:320–2.PubMed

11.

Poole KA, Weber N, Aziz M. Case report: quetiapine and refractory hypotension during general anesthesia in the operating room. Anesth Analg. 2013;117:641–3.CrossRefPubMed

12.

Palmer SE, McLean RM, Ellis PM, Harrison-Woolrych M. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. J Clin Psychiatry. 2008;69:759–68.CrossRefPubMed

13.

Leung JG, Puri NV, Jacobson MJ. Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea. Ann Pharmacother. 2011;45:e45.CrossRefPubMed

14.

Minns AB, Clark RF. Toxicology and overdose of atypical antipsychotics. J Emerg Med. 2012;43:906–13.CrossRefPubMed

15.

Taylor D, Paton C, Kapur S. South London and Maudsley NHS Trust. The Maudsley prescribing guidelines in psychiatry. 11th ed. Chichester: John Wiley & Sons; 2012.

16.

Shiovitz TM, Welke TL, Tigel PD, et al. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophr Bull. 1996;22:591–5.CrossRefPubMed

17.

Stevenson E, Schembri F, Green DM, Burns JD. Serotonin syndrome associated with clozapine withdrawal. JAMA Neurol. 2013;70:1054–5.CrossRefPubMed

18.

Ahmed S, Chengappa KN, Naidu VR, Baker RW, Parepally H, Schooler NR. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series. J Clin Psychiatry. 1998;59:472–7.CrossRefPubMed

19.

Wadekar M, Syed S. Clozapine-withdrawal catatonia. Psychosomatics. 2010;51:355.CrossRefPubMed

20.

Flexman AM, Ryerson CJ, Talke PO. Hemodynamic stability after intraarterial injection of verapamil for cerebral vasospasm. Anesth Analg. 2012;114:1292–6.CrossRefPubMed

21.

Keuskamp J, Murali R, Chao KH. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2008;108:458–63.CrossRefPubMed

Title: Failure of Induced Hypertension for Symptomatic Vasospasm in the Setting of Clozapine Therapy
Authors: Jonathan G. Leung
Sarah Nelson
Sara Hocker
Publication date: 01-12-2015
Publisher: Springer US
Published in: Neurocritical Care / Issue 3/2015
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-015-0129-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Failure of Induced Hypertension for Symptomatic Vasospasm in the Setting of Clozapine Therapy

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2015

Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain

Mandatory Intensivist Management Decreases Length of Stay, Facilitates an Increase in Admissions and Minimizes Closure of a Neurocritical Care Unit

Blood Pressure Guideline Adherence in Patients with Ischemic and Hemorrhagic Stroke in the Neurointensive Care Unit Setting

Neuro-Intensivists as Effective Resource Managers. No, Really

Cerebral Taurine Levels are Associated with Brain Edema and Delayed Cerebral Infarction in Patients with Aneurysmal Subarachnoid Hemorrhage

Dynamic Autoregulatory Response After Aneurysmal Subarachnoid Hemorrhage and Its Relation to Angiographic Vasospasm and Clinical Outcome